# Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

> **NCT04286789** · PHASE1 · COMPLETED · sponsor: **Oryn Therapeutics, LLC** · enrollment: 17 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Low dose ORTD-1
- **DRUG:** Low dose vehicle control
- **DRUG:** High dose ORTD-1
- **DRUG:** High dose vehicle control

## Key facts

- **NCT ID:** NCT04286789
- **Lead sponsor:** Oryn Therapeutics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2021-10-12
- **Final completion:** 2021-10-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04286789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04286789, "Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04286789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*